

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops Alloc...
Q1 2026
Jun 22, 2026
FY 2025
Mar 25, 2026
Q4 2025
Mar 25, 2026
Q3 2025
Nov 14, 2025
Q2 2025
Aug 29, 2025